Motus GI Holdings, Inc. (MOTS)
| Market Cap | 49.55M |
| Revenue (ttm) | 98,000 |
| Net Income (ttm) | -19.26M |
| Shares Out | 32.12M |
| EPS (ttm) | -0.60 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 7 |
| Last Price | $1.06 |
| Previous Close | $1.05 |
| Change ($) | 0.01 |
| Change (%) | 0.95% |
| Day's Open | 1.05 |
| Day's Range | 1.04 - 1.08 |
| Day's Volume | 1,225,970 |
| 52-Week Range | 0.68 - 2.74 |
- - - - The article states Pure-Vu System is estimated to provide lifetime saving of $833- $992 per patient when compared to standard of care for outpatient colorectal cancer (CRC) screening and surveil...
Motus GI Holdings, Inc. (MOTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Motus GI Holdings (MOTS) stock is on the rise Friday following clearance from the FDA for one of the company's medical devices. The post MOTS Stock: The Big FDA News That Has Motus GI Holdings Soaring T...
Tech penny stocks are back in focus; check these 3 out The post Penny Stocks to Buy? Check These Tech Stocks Out appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
FORT LAUDERDALE, Fla., April 30, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...
FORT LAUDERDALE, Fla., April 29, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...
Motus GI Holdings Inc (NASDAQ: MOTS) has submitted a 510(k) application to the FDA for a version of the Pure-Vu System. The new version of the system is compatible with gastroscopes used during upper ga...
Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 0.00% and -61.29%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
FORT LAUDERDALE, Fla., March 16, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...
FORT LAUDERDALE, Fla., March 15, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...
Motus GI Holdings, Inc. (MOTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FORT LAUDERDALE, Fla., March 02, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...
FORT LAUDERDALE, Fla., March 01, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve c...
FORT LAUDERDALE, Fla., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve cl...
Regulatory approval for enhanced system is a key milestone that supports evaluation of strategic partnership opportunities in the EU - - - U.S. commercial rollout of Pure-Vu® GEN2 System enhancements in...
Receives additional EU Patent for the Pure-Vu® System that protects the design of its fecal waste evacuation channels Receives additional EU Patent for the Pure-Vu® System that protects the design of it...
FORT LAUDERDALE, Fla., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve cl...
Motus GI Holdings, Inc.'s (MOTS) CEO Tim Moran on Q3 2020 Results - Earnings Call Transcript
FORT LAUDERDALE, Fla., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve cl...
FORT LAUDERDALE, Fla., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions to help improv...
FORT LAUDERDALE, Fla., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve cl...
FORT LAUDERDALE, Fla., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve cl...
FORT LAUDERDALE, Fla., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve...
FORT LAUDERDALE, Fla., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that impro...
FORT LAUDERDALE, Fla., Aug. 28, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve ...
Motus GI Holdings, Inc.'s (MOTS) CEO Tim Moran on Q2 2020 Results - Earnings Call Transcript
Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 28.57% and -95.00%, respectively, for the quarter ended June 2020.
Shares of Motus GI Hldgs (NASDAQ: MOTS) were flat after the company reported Q2 results.
FORT LAUDERDALE, Fla., July 21, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improv...
FORT LAUDERDALE, Fla., June 15, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve ...
Live moderated video webcast discussion with CEO, Tim Moran on Monday, June 15, at 2:00 PM ET, immediately followed by an interactive Q&A session Live moderated video webcast discussion with CEO, Tim Mo...
Motus GI Holdings, Inc. (MOTS) CEO Tim Moran on Q1 2020 Results - Earnings Call Transcript
Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of -4.55% and -81.33%, respectively, for the quarter ended March 2020.
FORT LAUDERDALE, Fla., May 14, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve...
FORT LAUDERDALE, Fla., May 05, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...
Motus GI Holdings, Inc. (MOTS) CEO Tim Moran on Q4 2019 Results - Earnings Call Transcript
FORT LAUDERDALE, Fla., March 30, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that impro...
As of late, it has definitely been a great time to be an investor in Motus GI Holdings.
Motus GI Holdings, Inc. (MOTS) CEO Tim Moran on Q3 2019 Results - Earnings Call Transcript
Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 28.00% and -97.00%, respectively, for the quarter ended September 2019.
The GuruFocus All-in-One Screener can be used to find insider trades from the past week.
About MOTS
Motus GI Holdings, Inc., a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with colonoscopy in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.
| Industry Diagnostics & Research | IPO Date Feb 14, 2018 |
| CEO Timothy Moran | Employees 24 |
| Stock Exchange NASDAQ | Ticker Symbol MOTS |
Financial Performance
In 2020, MOTS's revenue was $98,000, a decrease of -8.41% compared to the previous year's $107,000. Losses were -$19.26 million, -16.59% less than in 2019.
Analyst Forecasts
According to 6 analysts, the average rating for MOTS stock is "Buy." The 12-month stock price forecast is 2.42, which is an increase of 128.30% from the latest price.